Brooklyn, NY, United States of America

Pavel Osten

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pavel Osten: Innovator in Psychiatric Treatment

Introduction

Pavel Osten is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of psychiatric treatment through his innovative patents. With a total of 2 patents, Osten's work focuses on improving therapeutic options for patients suffering from psychiatric disorders.

Latest Patents

Osten's latest patents include "Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders" and "Gaboxadol for reducing risk of suicide and rapid relief of depression." The first patent describes ring deuterated gaboxadol, which is shown to be more effective than its non-deuterated counterpart in treating psychiatric disorders. This compound can be used in combination with other medications to enhance therapeutic effects. The second patent outlines methods for rapidly reducing the risk of suicide in patients experiencing acute suicidality and providing quick relief from mood symptoms in major depression and treatment-resistant depression through a novel therapeutic regimen involving gaboxadol.

Career Highlights

Osten is currently associated with Certego Therapeutics Inc., where he continues to develop innovative solutions for mental health challenges. His work is characterized by a commitment to advancing psychiatric treatment options and improving patient outcomes.

Collaborations

Some of his notable coworkers include Kristin K Baldwin and Robert J DeVita, who contribute to the collaborative efforts at Certego Therapeutics Inc.

Conclusion

Pavel Osten's contributions to psychiatric treatment through his patents highlight his dedication to innovation in mental health care. His work not only advances scientific understanding but also offers hope for improved therapies for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…